Concepedia

M. Wagenaar

MW

Statistics

Publications

12

Citations

881

H-Index

11

Active since

2000

Affiliations

Pfizer (United States)(Current)

Cornell University

Pearl River Community College

M. Wagenaar is an author at Pfizer (United States) specializing in medicinal chemistry, life sciences, and drug discovery.

Publications per year

2000–2021

12

Publications

12

The Cytosporones, New Octaketide Antibiotics Isolated from an Endophytic Fungus

Sean F. Brady, M. Wagenaar, Maya P. Singh et al. · Organic Letters · 2000 · 202 citations

, , +16

Dicerandrols, New Antibiotic and Cytotoxic Dimers Produced by the Fungus <i>Phomopsis </i><i>l</i><i>ongicolla</i> Isolated from an Endangered Mint

M. Wagenaar, Jon Clardy · Journal of Natural Products · 2001 · 169 citations

, , +16

Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications

Andreas Maderna, Matthew Doroski, Chakrapani Subramanyam et al. · Journal of Medicinal Chemistry · 2014 · 132 citations

, , +17

Three New Cytochalasins Produced by an Endophytic Fungus in the Genus <i>Rhinocladiella</i>

M. Wagenaar, Jennifer Corwin, Gary A. Strobel et al. · Journal of Natural Products · 2000 · 130 citations

, , +15

Pre-fractionated Microbial Samples – The Second Generation Natural Products Library at Wyeth

M. Wagenaar · Molecules · 2008 · 74 citations · Full text

, , +15

1–5 of 12